EYSUVIS™ (loteprednol etabonate ophthalmic suspension) 0.25%

Eysuvis Now Approved Available In January 2021

Eysuvis Now Approved Available In January 2021

Eysuvis I Save Patient Access Program

Eysuvis I Save Patient Access Program

Full PRESCRIBING
INFORMATION
for EYSUVIS

EYSUVIS is a trademark of Kala Pharmaceuticals.
©2020 Kala Pharmaceuticals
All rights reserved.
US-EYS-2000176
December 2020

Terms of Use
Privacy Statement
Accessibility Policy
Contact Us